Clinical Trial Update: Prednisolone Addition for Patients With Recent-onset Psychotic Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial update on adding prednisolone for patients with recent-onset psychotic disorder; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorder Nos
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: UMC Utrecht | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: TERMINATED